Difference between revisions of "Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[unchecked revision][checked revision]
(Rejected the last text change (by TestEditor) and restored revision 14169 by Bailey.Glen)
 
(388 intermediate revisions by 13 users not shown)
Line 1: Line 1:
 +
Welcome!   
 +
 +
 +
We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books.  Please join the effort!   
 +
 +
 +
To volunteer: 
 +
 +
#Select a link in the table to your book(s) of interest to view specific authorship opportunities.  Additional books are in the process of being added.
 +
#'''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your disease page of interest.  You will be connected with an Associate Editor to help guide you through the process.
 +
#Complete the brief '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]''' to receive your log-in credentials.  Information on [[Description of CCGA Roles|<u>Authorship and Other Roles</u>]] with the CCGA is available.
 +
  
 
{| class="wikitable"
 
{| class="wikitable"
 +
|+BOOKS WITH CONTENT IN PROGRESS
 +
!Book Name
 +
!Book Edition
 +
!Book Acronym
 
|-
 
|-
−
|'''Disease'''||'''Page Type'''||'''Author'''||'''Associate Editor'''
+
|[[HAEM5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues]]
−
!Author Content (Pending or Complete)
+
|5th
−
!Editor Reviewed (Date)
+
|HAEM5
 
|-
 
|-
−
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR)
+
|[[CNS5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Central Nervous System]]
−
|
+
|5th
−
|
+
|CNS5
 
|-
 
|-
−
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
+
|[[GTS5:Volunteer Assignments and Opportunities|WHO Classification of Genetic Tumour Syndromes]]
−
| ||FQR
+
|5th
−
|
+
|GTS5
−
|
 
 
|-
 
|-
−
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
+
|[[BRST5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Breast]]
−
| ||FQR
+
|5th
−
|
+
|BRST5
−
|
 
 
|-
 
|-
−
|    Polycythaemia Vera  (PV)||Disease
+
|[[STBT5:Volunteer Assignments and Opportunities|WHO Classification of Soft Tissue and Bone Tumours]]
−
| ||FQR
+
|5th
−
|
+
|STBT5
−
|
 
 
|-
 
|-
−
|    Primary Myelofibrosis  (PMF)||Disease
+
|[[DIG5:Volunteer Assignments and Opportunities|WHO Classification of Digestive System Tumours]]
−
| ||FQR
+
|5th
−
|
+
|DIG5
−
|
+
|}
−
|-
+
 
−
|    Essential  Thrombocythaemia (ET)||Disease
+
 
−
| ||FQR
+
{| class="wikitable"
−
|
+
|+BOOKS COMING SOON
−
|
+
!Book Name
−
|-
+
!Book Edition
−
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
+
!Book Acronym
−
| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
 
−
| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Cutaneous  Mastocytosis||Disease
 
−
| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Systemic Mastocytosis||Disease
 
−
| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Mast Cell Sarcoma||Disease
 
−
| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
|    Refractory Cytopenia  of Childhood||Disease|| ||FQR
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|-
 
−
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''|| ||Jennelle Hodge (JH)
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|Therapy-Related Myeloid Neoplasms||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myelomonocytic Leukemia||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Monoblastic and Monocytic Leukemia||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Pure Erythroid Leukemia||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Basophilic Leukemia||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Panmyelosis with Myelofibrosis||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|Myeloid Sarcoma||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Leukemia Associated with Down  Syndrome||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Acute  Undifferentiated Leukemia||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease|| ||JH
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|-
 
−
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
 
−
|
 
−
|
 
−
|-
 
−
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|-
 
−
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
 
−
|
 
−
|
 
−
|-
 
−
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|       Monoclonal B-cell  Lymphocytosis||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|B-cell Prolymphocytic Leukemia||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|Splenic Marginal Zone Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|Hairy Cell Leukemia||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    Hairy Cell Leukemia  Variant||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|Lymphoplasmacytic Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|   Waldenstrom  Macroglobulinemia||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    Mu Heavy Chain  Disease||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|   Gamma Heavy Chain  Disease||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    Alpha Heavy Chain  Disease||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|Plasma Cell Neoplasms||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    Plasma Cell Myeloma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    Plasma Cell Myeloma  Variants||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    Plasmacytoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|           Primary  Amyloidosis||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|           Light Chain  and Heavy Chain Deposition Disease||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|         POEMS Syndrome||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|         TEMPI Syndrome||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|Follicular Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    Testicular Follicular  Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    In Situ Follicular  Neoplasia||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    Duodenal-Type  Follicular Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|Paediatric-Type Follicular Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|Mantle Cell Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
|    In Situ Mantle Cell  Neoplasia||Disease|| ||SP
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|-
 
−
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
 
−
|
 
−
|
 
−
|-
 
−
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|Lymphomatoid Granulomatosis||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|Plasmablastic Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|Primary Effusion Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|   Multicentric Castleman  Disease||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|Burkitt Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||Associate Editor??
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
−
|-
 
−
|Example||Example|| ||
 
−
|
 
−
|
 
 
|-
 
|-
−
|Example||Example|| ||
+
|[[EYE5:Volunteer Assignments and Opportunities|WHO Classification of Eye and Orbit Tumours]]
−
|
+
|5th
−
|
+
|EYE5
 
|-
 
|-
−
|Example||Example|| ||
+
|[[SKIN5:Volunteer Assignments and Opportunities|WHO Classification of Skin Tumours]]
−
|
+
|5th
−
|
+
|SKIN5
 
|-
 
|-
−
|Example||Example|| ||
+
|[[HAN5:Volunteer Assignments and Opportunities|WHO Classification of Head and Neck Tumours]]
−
|
+
|5th
−
|
+
|HAN5
 
|-
 
|-
−
|Example||Example|| ||
+
|[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]]
−
|
+
|5th
−
|
+
|ENDO5
 
|-
 
|-
−
|Example||Example|| ||
+
|[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]]
−
|
+
|5th
−
|
+
|MALE5
 
|-
 
|-
−
|Example||Example|| ||
+
|[[PEDS5:Volunteer Assignments and Opportunities|WHO Classification of Paediatric Tumours]]
−
|
+
|5th
−
|
+
|PEDS5
 
|-
 
|-
−
|Example||Example|| ||
+
|[[THOR5:Volunteer Assignments and Opportunities|WHO Classification of Thoracic Tumours]]
−
|
+
|5th
−
|
+
|THOR5
 
|-
 
|-
−
|Example||Example|| ||
+
|[[FEMA5:Volunteer Assignments and Opportunities|WHO Classification of Female Genital Tumours]]
−
|
+
|5th
−
|
+
|FEMA5
 
|}
 
|}

Latest revision as of 13:26, 22 February 2024

Welcome!


We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books. Please join the effort!


To volunteer:

  1. Select a link in the table to your book(s) of interest to view specific authorship opportunities. Additional books are in the process of being added.
  2. Contact us with your disease page of interest. You will be connected with an Associate Editor to help guide you through the process.
  3. Complete the brief Volunteer Form to receive your log-in credentials. Information on Authorship and Other Roles with the CCGA is available.


BOOKS WITH CONTENT IN PROGRESS
Book Name Book Edition Book Acronym
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 5th HAEM5
WHO Classification of Tumours of the Central Nervous System 5th CNS5
WHO Classification of Genetic Tumour Syndromes 5th GTS5
WHO Classification of Tumours of the Breast 5th BRST5
WHO Classification of Soft Tissue and Bone Tumours 5th STBT5
WHO Classification of Digestive System Tumours 5th DIG5


BOOKS COMING SOON
Book Name Book Edition Book Acronym
WHO Classification of Eye and Orbit Tumours 5th EYE5
WHO Classification of Skin Tumours 5th SKIN5
WHO Classification of Head and Neck Tumours 5th HAN5
WHO Classification of Endocrine and Neuroendocrine Tumours 5th ENDO5
WHO Classification of Urinary and Male Genital Tumours 5th MALE5
WHO Classification of Paediatric Tumours 5th PEDS5
WHO Classification of Thoracic Tumours 5th THOR5
WHO Classification of Female Genital Tumours 5th FEMA5
Retrieved from "https://ccga.io/index.php?title=Volunteer_Assignments_and_Opportunities&oldid=14191"